THE SENATE |
S.B. NO. |
1431 |
THIRTY-THIRD LEGISLATURE, 2025 |
S.D. 1 |
|
STATE OF HAWAII |
H.D. 1 |
|
|
|
|
|
||
|
A BILL FOR AN ACT
RELATING TO VIRAL HEPATITIS.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. The legislature finds that the department of health reports that
hepatitis B and C viral infections are associated with earlier deaths and
higher death rates in Hawaii. From 2000
to 2020, yearly mortality rates associated with hepatitis B were higher in
Hawaii compared to the entire United States, with three times higher death rates
in 2019 alone. These death rates were
notably higher among Asian and Pacific Islander residents compared to the rest
of the State. Furthermore, from 2018 to 2021,
eighty-eight per cent of Hawaii residents with hepatitis C died before reaching
average life expectancy for the rest of the State. These deaths continue to occur in Hawaii
despite the availability of effective tools to prevent, treat, and even cure
these infections. To address the burden
of viral hepatitis in Hawaii, the department of health has successfully
leveraged community and state partnerships to convene the "Hep Free 2030: The Hawai‘i Hepatitis Elimination
Strategy 2020-2030." The coalition
has made progress towards eliminating viral hepatitis by focusing on five
priority areas: awareness and education; access to services; advocacy at all
levels; equity in everything; and data for decision-making. In 2021, the legislature adopted House Concurrent
Resolution No. 59, H.D. 1, which found that continued coordination and ongoing
efforts are needed to further implement the statewide strategy to eliminate
viral hepatitis types A, B, and C in Hawaii.
However, there has been no state funding dedicated to the prevention,
management, and treatment of viral hepatitis infections.
Accordingly, the purpose of this Act is to expand
the State's capacity to address preventable morbidity and mortality from viral
hepatitis among Hawaii residents through established and innovative public
health interventions.
SECTION 2. Chapter 325, Hawaii Revised Statutes, is
amended by adding four new sections to part V to be appropriately designated
and to read as follows:
"§325- Definitions. As used in this part, "department"
means the department of health.
§325- Hepatitis prevention program. (a)
The department may establish and administer a hepatitis prevention program
to prevent morbidity and mortality among Hawaii residents due to hepatitis B and
hepatitis C.
(b) The hepatitis prevention program shall prioritize:
(1) Hepatitis awareness and education;
(2) Increasing
access to services;
(3) Assuring
health equity and addressing the social determinants of health as they relate to
hepatitis; and
(4) The
collection, analysis, and reporting of relevant data to support hepatitis prevention
and treatment.
§325- Awareness and education. The department shall develop and
implement throughout the State an educational program for the purpose of informing
the community how to identify and prevent hepatitis and aid in its early diagnosis.
In furtherance of the hepatitis prevention program, the department may assist and
cooperate with any or all territorial, state, and national organizations conducting
educational programs for the prevention and control of hepatitis.
§325- Prevention plan; screening; treatment
support. The department
shall develop a statewide, comprehensive hepatitis prevention plan. The plan shall include hepatitis screening
and services to support individuals with hepatitis to access care and
treatment. The department may work with
other government agencies, health care providers, health insurers, and
community stakeholders to improve overall rates of screening, diagnosis, and
treatment of hepatitis."
SECTION 3. Section 325-92, Hawaii Revised Statutes, is
amended to read as follows:
"[[]§325-92[]] Prenatal hepatitis B screening and treatment of
newborns. The department [of health]
may adopt rules necessary to provide appropriate hepatitis B screening of pregnant
women, including reporting and follow-up procedures for newborns of hepatitis B
carrier mothers. [The department may provide
medications necessary for the treatment of newborns of indigent and medically indigent
carrier mothers.]"
SECTION 4. Section 325-91, Hawaii Revised Statutes, is
repealed.
["[§325-91 Blood transfusion; hepatitis.] In the procuring, furnishing, donating, processing,
distributing or using of human whole blood, plasma, blood products or blood derivatives
for the purpose of injecting or transfusing in the human body, there shall be no
implied warranty that the blood, plasma, products or derivatives are free from the
virus of serum hepatitis as long as there is no known scientific test to detect
the virus of serum hepatitis."]
SECTION 5. There is appropriated out of the general revenues
of the State of Hawaii the sum of $
or so much thereof as may be necessary for fiscal year 2025-2026 and the same sum
or so much thereof as may be necessary for fiscal year 2026-2027 for the
establishment and implementation of the hepatitis prevention program, including
the establishment of the following positions within the department of health:
(1) One full-time equivalent (1.0 FTE) program specialist V position;
(2) One full-time equivalent (1.0 FTE) epidemiological specialist position; and
(3) One full-time equivalent (1.0 FTE) office assistant III position.
The sums appropriated shall
be expended by the department of health for the purposes of this Act.
SECTION 6. Statutory material to be repealed is bracketed and
stricken. New statutory material is
underscored.
SECTION 7. This Act shall take effect on July 1, 3000.
Report Title:
DOH; Viral Hepatitis; Prevention; Awareness; Education; Treatment Support; Positions; Appropriation
Description:
Establishes a Hepatitis Prevention Program within the Department of Health. Requires the Department of Health to develop and implement an educational program to inform the public on how to identify and prevent hepatitis and aid in its early diagnosis. Requires the Department of Health to develop a comprehensive statewide hepatitis prevention plan. Repeals outdated provisions related to hepatitis. Appropriates funds and establishes positions for the Hepatitis Prevention Program. Effective 7/1/3000. (HD1)
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.